Citation Impact
Citing Papers
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
2007 Standout
Graft microvascular disease in solid organ transplantation
2014 StandoutNobel
Risk‐adjusted relationship between voriconazole utilization and non‐melanoma skin cancer among lung and heart/lung transplant patients
2013
Lung transplantation in idiopathic pulmonary fibrosis: a systematic review of the literature
2014
Voriconazole Prophylaxis in Lung Transplant Recipients
2006
Antifungal Prophylaxis in Lung Transplantation—A World-wide Survey
2011
Perioperative Antibiotics in Thoracic Surgery
2011
Nebulized amphotericin B prophylaxis for Aspergillus infection in lung transplantation: study of risk factors
2001
Everolimus-based immunosuppressive regimens in lung transplant recipients: Impact on CMV infection
2014
Cytomegalovirus Pneumonitis Is a Risk for Bronchiolitis Obliterans Syndrome in Lung Transplantation
2010
Idiopathic pulmonary fibrosis
2017 Standout
Anti-Aspergillus Prophylaxis in Lung Transplantation: A Systematic Review and Meta-analysis
2013
Recommendations for Noninvasive Evaluation of Native Valvular Regurgitation
2017 Standout
Cystic fibrosis
2016 Standout
SAFETY OF AEROSOLIZED AMPHOTERICIN B LIPID COMPLEX IN LUNG TRANSPLANT RECIPIENTS12
2001
Aspergillus infections in lung transplant recipients: risk factors and outcome
2005
Updated International Consensus Guidelines on the Management of Cytomegalovirus in Solid-Organ Transplantation
2013
Immunosuppressive therapy in lung transplantation: state of the art
2009
Traumatic Tricuspid Papillary Muscle and Chordae Rupture: Emerging Role of Three‐Dimensional Echocardiography
2008
Bacterial and Fungal Pneumonias After Lung Transplantation
2008
Safety of aerosolized liposomal versus deoxycholate amphotericin B formulations for prevention of invasive fungal infections following lung transplantation: a retrospective study
2007
Aspergillosis in Solid Organ Transplantation
2013
Aspergillus Infection in Lung Transplant Recipients With Cystic Fibrosisa
2003
Fungal infections in solid organ transplantation
2007
Comparative safety of amphotericin B lipid complex and amphotericin B deoxycholate as aerosolized antifungal prophylaxis in lung-transplant recipients
2004
Blunt Trauma to the Heart and Great Vessels
1997
Invasive fungal infections in solid organ transplant recipients
2014
Liposomal amphotericin B: clinical experience and perspectives
2005
Variation in antifungal prophylaxis strategies in lung transplantation
2006
Prophylaxis with nebulized liposomal amphotericin B for Aspergillus infection in lung transplant patients does not cause changes in the lipid content of pulmonary surfactant
2013
Invasive fungal infections in lung transplantation: role of aerosolised amphotericin B
2008
CMV: Prevention, Diagnosis and Therapy
2013
Feasibility, tolerability, and outcomes of nebulized liposomal amphotericin B for Aspergillus infection prevention in lung transplantation
2010
Idiopathic pulmonary fibrosis
2017 Standout
The incidence of invasive aspergillosis among solid organ transplant recipients and implications for prophylaxis in lung transplants
2002
Aerosol Deposition of Lipid Complex Amphotericin-B (Abelcet) in Lung Transplant Recipients
2006
The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation
2018 Standout
Antifungal Prophylaxis with Voriconazole or Itraconazole in Lung Transplant Recipients: Hepatotoxicity and Effectiveness
2009
Co-infections in people with COVID-19: a systematic review and meta-analysis
2020 Standout
Diagnosis and treatment of pulmonary chronic GVHD: report from the consensus conference on clinical practice in chronic GVHD
2011
Aspergillus infections after lung transplantation: clinical differences in type of transplant and implications for management
2003
Nebulized Liposomal Amphotericin B Prophylaxis for Aspergillus Infection in Lung Transplantation: Pharmacokinetics and Safety
2009
The Effectiveness of Culture-Directed Preemptive Anti-Aspergillus Treatment in Lung Transplant Recipients at One Year After Transplant
2015
Tie2-dependent VHL knockdown promotes airway microvascular regeneration and attenuates invasive growth of Aspergillus fumigatus
2013 StandoutNobel
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Guidelines for enhanced recovery after lung surgery: recommendations of the Enhanced Recovery After Surgery (ERAS®) Society and the European Society of Thoracic Surgeons (ESTS)
2018 Standout
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Practical Guidelines: Lung Transplantation in Patients with Cystic Fibrosis
2014
Clinical practice guidelines for antimicrobial prophylaxis in surgery
2013 Standout
2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis
2016 Standout
Global and Multi-National Prevalence of Fungal Diseases—Estimate Precision
2017 Standout
AspergillusInfections in Transplant Recipients
2005
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Ganciclovir-Resistant Cytomegalovirus Infections among Lung Transplant Recipients Are Associated with Poor Outcomes despite Treatment with Foscarnet-Containing Regimens
2013
Tracheobronchial Manifestations ofAspergillusInfections
2011
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
2008 Standout
Is universal antifungal prophylaxis mandatory in lung transplant patients?
2013
Guidelines for Preventing Health-Care-Associated Pneumonia, 2003: Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee
2004 Standout
Cytomegalovirus disease and infection in lung transplant recipients in the setting of planned indefinite valganciclovir prophylaxis
2012
Role of mTOR inhibitors for the control of viral infection in solid organ transplant recipients
2016
Aerosolized Amphotericin B Lipid Complex as Adjunctive Treatment for Fungal Lung Infection in Patients with Cancer‐Related Immunosuppression and Recipients of Hematopoietic Stem Cell Transplantation
2013
Clopidogrel reduces post-transplant obliterative bronchiolitis
2013
Works of J.M. Borró being referenced
Recommendations on the use of everolimus in lung transplantation
2012
Conversion From Cyclosporine to Tacrolimus Stabilizes the Course of Lung Function in Lung Transplant Recipients With Bronchiolitis Obliterans Syndrome
2007
Efficiency and Safety of Inhaled Amphotericin B Lipid Complex (Abelcet) in the Prophylaxis of Invasive Fungal Infections Following Lung Transplantation
2008
Blunt chest injuries in 1696 patients
1992
Pneumonia After Lung Transplantation in the Resitra Cohort: A Multicenter Prospective Study
2007
Development of Neoplasms During Lung Transplantation Follow-up
2008
A Retrospective 12-Month Study of Conversion to Everolimus in Lung Transplant Recipients
2011
Steroid Withdrawal in Lung Transplant Recipients
2005
Éxito a largo plazo de un trasplante combinado de pulmón-riñón en un paciente con fibrosis quística
2013
Comparative Study of Basiliximab Treatment in Lung Transplantation
2005
Antifungal Prophylaxis During the Early Postoperative Period of Lung Transplantation
1999
Registro Español de Trasplante Pulmonar: primer informe de resultados (2006-2010)
2012
A Multicenter Study of Valganciclovir Prophylaxis up to Day 120 in CMV-Seropositive Lung Transplant Recipients
2009
The Spanish Lung Transplant Registry: First Report of Results (2006–2010)
2013
Long-term Success of Combined Kidney–Lung Transplantation in a Patient With Cystic Fibrosis
2013